C EREBRAL vasospasm following subarachnoid hemorrhage (SAH) due to a ruptured aneurysm is an important cause of cerebral ischemia, and is the leading cause of death and disability after aneurysm rupture. 5A3 '14 The pathogenesis of this condition is poorly understood, and previous studies have failed to yield conclusive evidence as to the causative agent(s) or the nature of the cerebral artery narrowing. ~4, 19 An increased incidence of circulating immune complexes (CIC) 27 and deposition of immunoglobulin (Ig)G and complement C3 in the cerebral arterial walls ~5 of patients with chronic vasospasm have been reported. This suggests that immunological reactions are involved in cerebral vasospasm. Circulating immune complexes are detected in a number of diseases, and their effects are primarily mediated by deposition in tissues and complement activation which causes an inflammatory cellular reaction, particularly in small vessels, renal glomeruli, and joints. A similar reaction has also been observed in and around cerebral vessels following aneurysm rupture. 12, 16, 29 In the present study, CIC as well as complement activation were monitored in a series of patients with ruptured saccular aneurysms. The findings were correlated to the outcome of the patients and to the development of angiographic vasospasm. Another group of patients with intracerebral hematoma unrelated to aneurysm rupture was also studied.
Clinical Material and Methods

Aneurysm Patients
The series included 19 patients (14 women and five men) who ranged in age from 29 to 68 years (mean age 51 years). The clinical data are summarized in Table 1 . The patients were selected in random order from an ongoing study of immunogenetic markers in aneurysm patients. 26 In each case the diagnosis was confirmed by computerized tomography (CT) scanning and preoperative cerebral angiography ( Table 1 ). The amount of blood in the subarachnoid space was estimated from CT scans obtained at 11 different loci and was graded from 0 to 33 according to the scoring system of Ljunggren, et al. 22 Patients with a large hematoma operated on within the first 24 hours after onset of symptoms were excluded. Since vasospasm usually occurs after 
Hematoma Patients
A group of seven patients admitted consecutively during the study period for treatment of intracerebral hematoma unrelated to aneurysm rupture was also investigated ( Table 3 ). The mean age in this group was 53 years (range 18 to 66 years). The diagnosis was confirmed by CT scanning and in two cases also by angiography. The patients' clinical status was graded according to the classification of Hunt and Hess.~7 Their functional capacity at the 3-month follow-up evaluation was assessed according to the Glasgow Outcome Scale,~8 which was also used to evaluate the outcome of the aneurysm patients (see Table 1 ).
Blood Sampling Procedure
Blood samples were obtained within the first 24 hours after bleeding (Day 1), and also on Days 2, 3, 7, 10, and 14. Plasma (ethylenediaminetetra-acetic acid (EDTA) in a final concentration of 10 mM/liter) or serum was separated after 90 minutes at room temperature and stored at -80"C until analyzed. Outcome determined by the Glasgow Outcome Scale. Is
Assay for Detection of CIC
The polyethylene glycol (PEG)-complement consumption assay was used to detect CIC. This assay has previously been described in detail.~ Briefly, the plasma and serum are each subjected to PEG precipitation followed by washings in PEG-6000 in borate buffer, pH 8.3 (final concentration of PEG 2.75% and 3.5%, respectively, for each of two serum assays), and the precipitate is resuspended in 0.15 M veronal buffer, pH 7.4, and mixed with guinea pig serum absorbed with sheep erythrocytes. The amount of guinea pig complement was adjusted to achieve optimal sensitivity in each experiment. Complement consumption is measured as a reduction of hemolytic capacity after the addition of sensitized sheep erythrocytes. The anti-complementary activity of each specimen, measured as inhibition of hemolysis, was expressed in arbitrary units from 0 (not detectable) to ++++ (high activity). Positivity for CIC was defined as the mean of control measurements _ 2 standard deviations (SD).
Quantification of C3d
The presence of C3d in EDTA-plasma was quantified by rocket immunoelectrophoresis using the intermediate gel technique as described in detail previously. 3~ This technique was performed in 1% modified Litex LSA agarose* in 0.028 M veronal buffer, pH 8.6. In order to avoid a pH gradient across the agarose during electrophoresis, double chambers were used on both the anode and cathode sites. The electrophoresis was run at 7.5 V/cm for 7 hours. The C3d concentration was corrected for changes in hemoconcentration. Normal values of C3d in 21 age-and sex-matched healthy blood donors ranged from 11 to 50 mU/ml (mean 22.2 mU/ml).
Statistical Analysis
The chi-square test, Fisher's exact test, Student's * Litex LSA agarose, Batch 4031, obtained from Litex Industria, Glostrup, Denmark. t-test for unpaired differences, the Wilcoxon-Mann-Whitney test, and analysis of variance (ANOVA) were used for statistical analysis. A p value less than 0.05 was considered significant.
Results
Clinical Findings
As shown in Table 1 , five of the 19 aneurysm patients died. Seven patients were moderately or severely disabled at 3 months, and seven patients had recovered completely. Vasospasm was demonstrated in nine of the 14 patients who underwent angiography between Days 4 and 12 after SAH ( Table 2 ). Due to late admission on Day 9, one patient (Case 1) was not included in the CT score calculations. 3~ The remaining 18 patients had a mean subarachnoid bleeding score on admission of 20.5 ___ 9.3 SD (range 2 to 31). There was no difference in CT score between patients with and without vasospasm.
Two of the hematoma patients died, three were disabled, and two recovered completely (Table 3) .
Circulating lmmune Complexes
Patients with Ruptured Aneurysm. At admission, CIC were detected in 13 (72%) of 18 patients with ruptured aneurysm ( (Table 3 ). These three patients remained CIC-positive throughout the study period, whereas two patients (Cases 22 and 25) became CICpositive from Day 7 and D a y 10, respectively, following cerebral hemorrhage. In this group, no association could be demonstrated between the o u t c o m e of the disease and the presence o f CIC. Table 4 shows the m e a n plasma levels o f C3d during the study period in the 19 a n e u r y s m patients and in the seven patients with cerebral h e m a t o m a unrelated to aneurysm rupture. The C3d levels on Days 1 to 3 following the onset o f s y m p t o m s in the different patient groups did not differ from those o f apparently healthy blood donors as determined by Student's t-test. On Days 7, 10, and 14, the C3d levels in aneurysm patients were significantly higher than those in blood donors but were not significantly higher than those in the h e m a t o m a patients (Student's t-test).
C o m p l e m e n t Activation
The levels o f c o m p l e m e n t C3d in the 14 aneurysm patients investigated angiographically for vasospasm later than D a y 3 after S A H are depicted in Fig. 1 . In the patients with angiographic vasospasm, there was a marked and sustained increase in the plasma C3d concentration after Day 3. In patients without spasm, the C3d levels remained close to those o f the healthy do-J. R. Ostergaard, et aL nors. Table 5 compares the mean plasma C3d levels _ SD from Days 7, l 0, and 14 in aneurysm patients with spasm (nine patients, G r o u p 1) and without spasm (five patients, G r o u p 2), in seven h e m a t o m a patients (Group 3), and in 21 blood donors (Group 4). As can be seen, the aneurysm patients with cerebral vasospasm (Group l) had significantly higher C3d levels than any o f the other three groups in this period (that is, during the 2nd week after onset o f symptoms). A positive association was found between the presence o f CIC on admission and the mean C3d levels on Days 7, 10, and 14, as well as between the presence o f CIC on admission and the mean increase in C3d concentration from the first 3 days following S A H to the 2nd week (Fig. 2 ). There was no correlation between CT score on admission and the C3d levels in the 2nd week after onset o f symptoms (Fig. 3) .
Two o f the h e m a t o m a patients developed severe breakthrough bleeding into the ventricles ( Table 3) 28.5 +-7.611 4 * Values are means + standard deviations (SD) for the 19 patients with ruptured cerebral aneurysms and for the seven patients with cerebral hemorrhage unrelated to aneurysm rupture. The mean value _+ SD for 21 age-and sex-matched blood donors was 22.2 +-9.6 mU/ ml. According to Student's t-test, the significance when compared to the mean value for blood donors was as follows: ~c p < 0.01; w p < 0.05; and II not significant.
t Among hematoma patients no difference in plasma C3d levels was found between the 6 post-hemorrhage days (p > 0.1, analysis of variance). In aneurysm patients a significant increase in plasma C3d levels was found after Day 3 (p < 0.01, analysis of variance). Immune complexes and complement activation following SAH vasospasm, a poor prognosis, and complement activation.
A high incidence of CIC in aneurysm patients with angiographic and/or clinical vasospasm has previously been reported. 27 In that study, however, only one blood sample was obtained from each patient and the sample was drawn at different times following the SAH. Thus, the time course for the formation of the CIC and the possible pathophysiological role of CIC in the development of the spasm were not elucidated. Our study confirms that patients with SAH from ruptured aneurysms have a high incidence of CIC. In this context it should be emphasized that the prevalence of CIC in our control blood donors is close to that found by others. 9,28 Moreover, our investigation showed that the CIC were present at admission to the hospital, which for some patients occurred within the first 10 hours after SAH. The CIC must therefore have been formed either very shortly after the hemorrhage or even before the aneurysm ruptured, and thus were present before spasm usually developed. 14' 19"2~' 33 A high incidence of CIC has previously been found in patients with various vascular disorders, 8 particularly in patients with acute myocardial infarction. 7, 9, 28 In the present study, two of the three CIC-positive hematoma patients were hypertensive and had previously suffered a vascular accident. Of the 13 CIC-positive aneurysm patients, five were hypertensive and three of these had previously suffered a major cerebral stroke. However, since CIC were present in eight of 12 aneurysm patients who neither suffered from hypertension nor had experienced a vascular event, the presence of CIC in aneurysm patients cannot be solely ascribed to such disorders. On the other hand, the majority of aneurysm patients admitted to the hospital experience warning symptoms days to months before a major hemorrhage occurs. 6,~~176 The early occurrence of CIC in aneurysm patients may therefore be explained by the repeated leakage of small amounts of blood into the subarachnoid space with concomitant release of damaged tissue, which may act as an autoantigen. The specimens remained CIC-positive throughout the 2week study period, and one aneurysm patient and two hematoma patients became CIC-positive during the study. This could be explained by a continuous release of damaged tissue which maintained production of the CIC.
A pathogenetic role of CIC in disease depends on whether the CIC are deposited in tissues and whether they activate complement. Deposition of IgG and complement C3 in the cerebral arterial wall has previously been reported in patients with chronic vasospasm) 5 In the present study we found that patients who developed angiographic arterial narrowing, in contrast to patients who did not, exhibited a twofold increase in C3d levels, a sensitive marker for complement activation. 2'3~ Moreover, it was found that the increase in C3d was positively associated with the presence of CIC. Our findings thus suggest that the demonstrated CIC had complementactivating properties, but the plasma C3d may also have been generated locally due to an antigen-antibody reaction around the affected vessels.
The complement system can be regarded as a principal effector mechanism of inflammation in immune complex-mediated diseases. 23 Inflammatory cellular reactions with accumulation of polymorphonuclear leukocytes in and around cerebral vessels following aneurysm rupture have repeatedly been reported. 12 ' 16' 29 Complement has also been shown to solubilize immune complexes and thereby enhance their removal. 24 The observed association between complement activation, CIC, and vasospasm may thus be either a primary or a secondary phenomenon. In the latter case, it should be expected that hematoma patients would also have shown an increase in the plasma concentration of C3d; however, this was not found. Moreover, no correlation could be demonstrated between the amounts of blood in the subarachnoid space and C3d. The present findings therefore suggest that immunological reactions are involved in the pathogenesis of cerebral vasospasm following aneurysm rupture. Further evidence of a possible involvement of immunological processes comes from the clinical observation that a rebleeding episode induces vasospasm earlier than does the primary hemorrhage. 21 This may illustrate the rapid secondary "immune" response following a more slowly developing primary response. The findings support the concept that administration of high-dose methylprednisolone (30 mg/kg), which can be expected to inhibit complement-induced immune injuries, ~ may be of benefit in aneurysm patients. Prevention of chronic vasospasm in a "double-hemorrhage" canine model has been obtained using this regimen. 3'4
